Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A case of EGFR mutation-positive lung adenocarcinoma in which the T790M allele fraction was increased by repeated EGFR-TKI treatment.

Cancer communications (London, England) - 1 Nov 2019

Kimura Hideharu, Amino Yoshiaki, Koba Hayato, Tambo Yuichi, Ohkura Noriyuki, Hara Johsuke, Sone Takashi, Kasahara Kazuo

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Alleles
Share to Antineoplastic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Mutation

Share to Protein Kinase Inhibitors

Source

Open in PubMed Open full text

Identifiers

PMID: 31675980
DOI: 10.1186/s40880-019-0413-5
PMCID: PMC6823937

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

A case of EGFR mutation-positive lung adenocarcinoma in which the T790M allele fraction was increased by repeated EGFR-TKI treatment.PMID 31675980Read ↗

A patient with a Germline (p.R776H) EGFR Mutation With Multiple Lung Cancers Harboring Different Somatic EGFR Mutations.Semantic proximity Read ↗

Dynamic Changes and Drug-Induced Selection of Resistant Clones in a Patient With EGFR-Mutated Adenocarcinoma That Acquired T790M Mutation and Transformed to Small-Cell Lung Cancer.Semantic proximity Read ↗

Acquired resistance of pulmonary adenocarcinoma to initially successful targeted therapy due to EGFR mutation T790M.Semantic proximity Read ↗

Unique natural history of an EGFR mutated adenocarcinoma.Semantic proximity Read ↗

The emergence of T790M mutation in EGFR-mutant lung adenocarcinoma patients having a history of acquired resistance to EGFR-TKI: focus on rebiopsy timing and long-term existence of T790M.Semantic proximity Read ↗

Disappearance of an activated EGFR mutation after treatment with EGFR tyrosine kinase inhibitors.Semantic proximity Read ↗

A Case of Adenocarcinoma of the Lung With EGFR T790 Mutation Presenting With Chylous Ascites.Semantic proximity Read ↗

EGFR mutation status in pleural fluid predicts tumor responsiveness and resistance to gefitinib.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.